洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR1900024349】The Hong Kong Mental Morbidity Survey for Older People

基本信息
登记号

ChiCTR1900024349

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2019-07-06

临床申请受理号

/

靶点

/

适应症

Dementia

试验通俗题目

The Hong Kong Mental Morbidity Survey for Older People

试验专业题目

The Hong Kong Mental Morbidity Survey for Older People

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

Population ageing has become a major public health concern. Dementia and mental disorders affect independent functioning and pose significant burden to the patients and their families. With changing demographics in the Hong Kong ageing community, an update on prevalence estimates of dementia and late life mental disorders is required for good health care planning. The Hong Kong Mental Morbidity Survey for Older People (HKMMSOP) aims to evaluate: 1) prevalence of dementia and its subtypes, common mental disorders and psychosis syndromes in Hong Kong adults aged 60 or over; 2) modulating factors for disease development or functional optimization; 3) disease burden and cost of care.

试验分类
请登录查看
试验类型

连续入组

试验分期

其它

随机化

N/A

盲法

N/A

试验项目经费来源

Health and Medical Research Fund

试验范围

/

目标入组人数

6000

实际入组人数

/

第一例入组时间

2019-07-09

试验终止时间

2021-06-30

是否属于一致性

/

入选标准

1. Aged 60 years or over; 2. Consent for participation. For subjects who are willing to participate, but are unavailable or unable to provide full information (e.g. profound cognitive impairments or sensory deficits), proxy information from first degree relatives will be obtained and the data will be specified as proxy.;

排除标准

Those who are non-Chinese and the prison population will not be covered in this survey.;

研究者信息
研究负责人姓名
请登录查看
试验机构

Food and Health Bureau, Hong Kong SAR Government

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Food and Health Bureau, Hong Kong SAR Government的其他临床试验

香港中文大學的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用